Eurofins CDMO Alphora Inc. Announces Completion of New API Manufacturing Facility

Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization, excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing facility at its site in Mississauga, Canada. The new API facility adds 15,000 sq ft of GMP processing and warehousing space which complements Eurofins CDMO Alphora’s existing API and drug substance manufacturing capabilities.

Eurofins CDMO Alphora Inc. is an OBIO® member.

Previous
Previous

SheBoot Announces 2024 Cohort

Next
Next

Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada & BC